Skip to content
10-Q

Quarterly Report

Auspex Pharmaceuticals, Inc.

0001564590-14-002127

← back to feed
Filed
May 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 12, 2014 23.61M sh
Stock Repurchased Q1 2014 · Mar 31, 2014 $32K
Capex Q1 2014 · Mar 31, 2014 $34K
Capex Q1 2014 · Mar 31, 2014 $1.73M
Long Term Debt Q1 2014 · Mar 31, 2014 $15M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $26.61M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $36.65M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $2M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $4.28M
Stockholders Equity Q1 2014 · Mar 31, 2014 $101.53M
Stockholders Equity Q1 2014 · Dec 31, 2013 −$64.94M
Current Liabilities Q1 2014 · Mar 31, 2014 $4.86M
Current Liabilities Q1 2014 · Dec 31, 2013 $3.49M
Total Liabilities Q1 2014 · Mar 31, 2014 $19.43M
Total Liabilities Q1 2014 · Dec 31, 2013 $21.96M
Current Assets Q1 2014 · Mar 31, 2014 $120.77M
Current Assets Q1 2014 · Dec 31, 2013 $36.89M
Total Assets Q1 2014 · Mar 31, 2014 $120.96M
Total Assets Q1 2014 · Dec 31, 2013 $38.87M
Sga Expense Q1 2014 · Mar 31, 2014 $2.67M
Sga Expense Q1 2014 · Mar 31, 2014 $22.42M
Sga Expense Q1 2014 · Mar 31, 2013 $899K
Rd Expense Q1 2014 · Mar 31, 2014 $3.43M
Rd Expense Q1 2014 · Mar 31, 2014 $48.18M
Rd Expense Q1 2014 · Mar 31, 2013 $1.73M
Net Income Q1 2014 · Mar 31, 2014 −$10.12M
Net Income Q1 2014 · Mar 31, 2014 −$75.6M
Net Income Q1 2014 · Mar 31, 2013 −$2.31M
Operating Income Q1 2014 · Mar 31, 2014 −$6.11M
Operating Income Q1 2014 · Mar 31, 2014 −$67.51M
Operating Income Q1 2014 · Mar 31, 2013 −$2.63M